Experiences with

Atazanavir

1 public post

FDA Approves Two Combination Therapies for HIV

Evotaz by Bristol-Myers Squibb is a combination of 300 mg atazanavir (Reyataz, Bristol-Myers Squibb) and 150 mg cobicistat (a pharmacokinetic enhancer by Gilead Sciences), which should be used with other antiretroviral agents. Evotaz should be dosed once a day. Read more http://bit.ly/1yga8lR
mwright profile image
Want to take advantage of all our features? Just log in!
or
    Filter results
    Posted in
    Sort by